These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7154348)

  • 21. Effect of the calcium antagonists nifedipine, nitrendipine, nimodipine and nisoldipine on oesophageal motility in man.
    Konrad-Dalhoff I; Baunack AR; Rämsch KD; Ahr G; Kraft H; Schmitz H; Weihrauch TR; Kuhlmann J
    Eur J Clin Pharmacol; 1991; 41(4):313-6. PubMed ID: 1804645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of secretin on lower esophageal sphincter pressure in patients with esophageal achalasia.
    Miyata M; Sakamoto T; Hashimoto T; Nakamura M; Sakaguchi H; Kawashima Y
    Gastroenterol Jpn; 1991 Dec; 26(6):712-5. PubMed ID: 1765245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A study on the effects of clinical drugs on lower esophageal sphincter pressure. Particularly on the relation with clinical drugs].
    Muraoka T
    Nihon Ika Daigaku Zasshi; 1983 Apr; 50(2):271-81. PubMed ID: 6134750
    [No Abstract]   [Full Text] [Related]  

  • 24. Idiopathic achalasia: are there different types?
    Castell DO
    Am J Gastroenterol; 1992 Dec; 87(12):1693-4. PubMed ID: 1449127
    [No Abstract]   [Full Text] [Related]  

  • 25. Balloon dilation of the esophago-gastric junction affects lower and upper esophageal sphincter function in achalasia.
    Wauters L; Van Oudenhove L; Selleslagh M; Vanuytsel T; Boeckxstaens G; Tack J; Omari T; Rommel N
    Neurogastroenterol Motil; 2014 Jan; 26(1):69-76. PubMed ID: 24004089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pentagastrin and gastric alkalinization on lower esophageal sphincter pressure in diffuse esophageal spasm.
    Eckardt VF; Holtermüller KH
    Digestion; 1975; 13(1-2):1-7. PubMed ID: 1201815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical therapy of achalasia: A benefit reserved for few.
    Bortolotti M
    Digestion; 1999; 60(1):11-6. PubMed ID: 9892793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of nifedipine on canine LESP (author's transl)].
    Hongo M
    Nihon Heikatsukin Gakkai Zasshi; 1981 Jun; 17(2):47-51. PubMed ID: 7328957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nifedipine: a potent inhibitor of contractions in the body of the human esophagus. Studies in healthy volunteers and patients with the nutcracker esophagus.
    Richter JE; Dalton CB; Buice RG; Castell DO
    Gastroenterology; 1985 Sep; 89(3):549-54. PubMed ID: 4018501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isosorbide dinitrate or nifedipine: which is preferable in the medical therapy of achalasia?
    Bortolotti M; Coccia G; Brunelli F; Sarti P; Mazza M; Bagnato F; Barbara L
    Ital J Gastroenterol; 1994; 26(8):379-82. PubMed ID: 7703511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: pharmacological options in achalasia.
    Bassotti G; Annese V
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1391-6. PubMed ID: 10571593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium-channel blocking agents for gastrointestinal disorders.
    Castell DO
    Am J Cardiol; 1985 Jan; 55(3):210B-213B. PubMed ID: 3881916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Esophageal achalasia with apparently normal relaxation of the lower sphincter: clinical significance and therapeutic response to pneumatic dilatation].
    Garrigues Gil V; Ponce García J; Pertejo Pastor V; Gálvez Castillo C; Valverde de la Osa J; Berenguer Lapuerta J
    Rev Esp Enferm Dig; 1996 Aug; 88(8):529-32. PubMed ID: 8962756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium antagonists in the treatment of cardiovascular disease.
    Postgrad Med J; 1983; 59 Suppl 2():1-122. PubMed ID: 6889215
    [No Abstract]   [Full Text] [Related]  

  • 35. [Intra-sphincter botulin toxin injection for therapy of achalasia].
    Kölbel CB; Singer MV
    Z Gastroenterol; 1996 Aug; 34(8):512-3. PubMed ID: 8967125
    [No Abstract]   [Full Text] [Related]  

  • 36. Achalasia: the usefulness of manometry for evaluation of treatment.
    Alonso P; González-Conde B; Macenlle R; Pita S; Vázquez-Iglesias JL
    Dig Dis Sci; 1999 Mar; 44(3):536-41. PubMed ID: 10080146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of lower esophageal sphincter function in symptomatic diffuse esophageal spasm.
    DiMarino AJ
    Gastroenterology; 1974 Jan; 66(1):1-6. PubMed ID: 4809495
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospective clinical and manometric study comparing pneumatic dilatation and sublingual nifedipine in the treatment of oesophageal achalasia.
    Coccia G; Bortolotti M; Michetti P; Dodero M
    Gut; 1991 Jun; 32(6):604-6. PubMed ID: 2060867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview of the role of calcium antagonists in the treatment of achalasia and diffuse oesophageal spasm.
    Short TP; Thomas E
    Drugs; 1992 Feb; 43(2):177-84. PubMed ID: 1372216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower esophageal sphincter dysfunction in achalasia.
    Cohen S; Lipshutz W
    Gastroenterology; 1971 Dec; 61(6):814-20. PubMed ID: 5125682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.